Ionis Pharmaceuticals (IONS) Prepaid Assets (2009 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly Prepaid Assets of $306.1 million in Q1 2026, up 29.1% quarter-over-quarter from $237.1 million in Q4 2025, and up 37.52% on a YoY basis from $222.6 million in Q1 2025.
Ionis Pharmaceuticals (IONS) Prepaid Assets (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $306.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 37.52% year-over-year to $306.1 million; the TTM figure through Mar 2026 stood at $306.1 million (up 37.52% YoY), while the FY2025 annual figure was $237.1 million, up 8.79% from the prior year.
- Prepaid Assets was $306.1 million for Q1 2026 at Ionis Pharmaceuticals, up from $237.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $306.1 million in Q1 2026 to a low of $142.8 million in Q2 2022.
- Historically, Prepaid Assets has averaged $196.2 million across 5 years, with a median of $184.2 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Prepaid Assets grew 1.72% in 2024, then surged 37.52% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $168.3 million in 2022, then gained by 22.1% to $205.4 million in 2023, then climbed by 6.09% to $217.9 million in 2024, then gained by 8.79% to $237.1 million in 2025, then rose by 29.1% to $306.1 million in 2026.
- The last three Prepaid Assets figures came in at $306.1 million (Q1 2026), $237.1 million (Q4 2025), and $243.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 306.08 Mn |
| Dec 31, 2025 | 237.09 Mn |
| Sep 30, 2025 | 243.74 Mn |
| Jun 30, 2025 | 226.11 Mn |
| Mar 31, 2025 | 222.57 Mn |
| Dec 31, 2024 | 217.93 Mn |
| Sep 30, 2024 | 184.19 Mn |
| Jun 30, 2024 | 194.72 Mn |
| Mar 31, 2024 | 174.06 Mn |
| Dec 31, 2023 | 205.43 Mn |
| Sep 30, 2023 | 181.08 Mn |
| Jun 30, 2023 | 177.87 Mn |
| Mar 31, 2023 | 159.72 Mn |
| Dec 31, 2022 | 168.25 Mn |
| Sep 30, 2022 | 143.17 Mn |
| Jun 30, 2022 | 142.76 Mn |
| Mar 31, 2022 | 150.58 Mn |
| Dec 31, 2021 | 143.37 Mn |
| Sep 30, 2021 | 136.64 Mn |
| Jun 30, 2021 | 131.05 Mn |